Loading...
XSHE
300272
Market cap476mUSD
Jul 10, Last price  
5.43CNY
1D
2.65%
1Q
-32.96%
Jan 2017
-35.91%
IPO
16.69%
Name

Canature Health Technology Group Co Ltd

Chart & Performance

D1W1MN
XSHE:300272 chart
P/E
59.28
P/S
1.80
EPS
0.09
Div Yield, %
3.21%
Shrs. gr., 5y
-0.07%
Rev. gr., 5y
4.02%
Revenues
1.84b
+9.03%
96,040,612124,941,633165,041,363207,070,109240,717,358311,205,792374,737,699456,841,410642,995,032707,501,599901,022,8201,052,525,4981,181,121,6361,511,487,4281,511,487,4281,660,642,4471,660,642,4461,671,699,3751,688,500,8551,840,952,624
Net income
56m
-32.98%
12,218,92626,268,81436,481,46239,734,70749,801,80156,974,12364,236,56076,012,56990,249,61458,010,095348,011,252100,512,74726,417,600104,859,883104,859,89192,561,92492,561,931132,446,68883,575,73156,008,942
CFO
300m
+3.44%
21,552,07219,418,45625,957,67047,729,40638,261,39339,690,31847,844,41380,250,32680,417,95949,975,30940,016,37696,051,452114,397,474140,429,986186,767,653155,435,268374,830,410289,639,323299,605,328
Dividend
Nov 18, 20250.05 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Canature Health Technology Group Co., Ltd. engages in the research, development, manufacture, sale, and service of residential water treatment products. It operates through the following business segments: Water purification and softening equipment, Fireplace and furnace equipment, Maintenance, and Cell storage and other services. Its products include whole house water purifiers, whole house water softeners, commercial purification water dispensers, reverse osmosis membrane water purifiers, multi-control valves, and composite pressure vessels. The company was founded by Jian Guo Qu on February 27, 2001 and is headquartered in Shanghai, China.
IPO date
Nov 02, 2011
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122023‑002022‑122022‑002021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT